Watch Joshua Meeks, MD, PhD, recap a session at the #AUA24 Meeting titled, “Harnessing Innovation in Bladder Cancer Care: Expert Strategies for Effectively Implementing Modern Therapeutic Advances Across the Disease Continuum.” Urology Times Lurie Cancer Center urologytimes.com/view/dr-meeks-…

Real-world data show high routine use of darolutamide regimens in community urology settings for patients with metastatic hormone-sensitive prostate cancer. #AUA24 #mHSPC #urology UrologyCentersAL
urologytimes.com/view/real-worl…

Get ready to elevate your practice and expand your network with Urology Times® Events coming to a city near you in 2024! Sign up for our eNewsletter to be the first to know about events in your area! ow.ly/S0m950RxwAc

Dr. Sarah P. Psutka shares details on the 'Get Moving Trial,' exploring at-home prehabilitation for patients with muscle-invasive bladder cancer. #AUA24 Sarah P. Psutka MD MS UW Urology #urology
urologytimes.com/view/dr-psutka…

Honored to have shared insights alongside of great colleagues Evan Kovac , David I Lee, MD , Firas Abdollah . Grateful for the opportunity Urology Times to contribute to such an important conversation . #AUA2024 , Cleveland Clinic Urology

Such a great conversation! Stay tuned for their insights!

UGN-101 showed efficacy in a broad population of patients with upper tract urothelial cancer and recurrence-free survival rates were high among patients who responded to UGN-101 induction therapy. #AUA24 #bladdercancer
urologytimes.com/view/response-…

Dr. Roger Li discusses the background and design of the phase 3 MoonRISe-1 study, evaluating the TAR-210 delivery system in patients with NMIBC. Roger Li #AUA24 #urology
urologytimes.com/view/dr-li-on-…

The prostatic urethral lift was found to be superior to medical therapy with tamsulosin (Flomax) in the treatment of LUTS secondary to BPH. #AUA24 #urology
urologytimes.com/view/urethral-…

The erdafitinib intravesical delivery system TAR-210 was safe and showed strong initial efficacy in patients with non–muscle-invasive bladder cancer with select FGFR alterations. #AUA24 #bladdercancer
urologytimes.com/view/tar-210-s…

Combining shockwave therapy and platelet rich plasma is safe for the treatment of patients with ED; however, it remains unclear if the combination provides an efficacy benefit. #AUA24 #erectiledysfunction urologytimes.com/view/combo-of-…

Just finished up an insightful interview with Dr. Matthew Nielsen, who discussed the progress made from the Census and AQUA data over the past 10 years as well as what’s still to come. Be on the lookout for Dr. Nielsen’s insights! #AUA24 #urology Matt Nielsen, MD Urology@UNC

“At 60 months, nadofaragene allowed bladder preservation in nearly half of the patients in the CIS cohort and two-thirds of patients in the Ta/T1 cohort,” said Vikram Narayan, MD. #AUA24 #bladdercancer Vikram M. Narayan, MD
urologytimes.com/view/nadofarag…

I very much appreciate the opportunity given to me by Urology Times to highlight some of the important work being presented at the #AUA24 Amer. Urol. Assn. annual meeting.

Dr. Roger R. Dmochowski discusses the use of implantable tibial neuromodulation devices as an earlier line of therapy for patients with overactive bladder. #AUA24 #OAB #urology Vanderbilt Urology
urologytimes.com/view/dr-dmocho…

First results from the NURE-Combo trial showed that neoadjuvant nivolumab and nab-paclitaxel appears to be safe and effective in patients with muscle-invasive bladder cancer. #AUA24 #MIBC #bladdercancer Chiara Mercinelli urologytimes.com/view/combinati…

Dr. Angela B. Smith highlights productivity hacks for urologists. #AUA24 #urology Angie Smith Urology@UNC
urologytimes.com/view/dr-smith-…

'But having the [BCG] shortage, I think, has ultimately led to a bottleneck and then an explosion in the technology and the resources and the techniques to treat patients with non–muscle-invasive bladder cancer,' says Dr. Joshua Meeks. | #AUA24 NM Urology
urologytimes.com/view/dr-meeks-…

Our team just had a great interview with Dr. J Stuart Wolf Jr MD FACS, who discussed empowering physician leaders and advances in kidney cancer. Stay tuned for his insights! #AUA24 #urology